Shira Yair

Title: Shira Yair: Innovator in Humanized Antibodies

Introduction

Shira Yair is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. Her work focuses on innovative solutions for treating immune-related disorders.

Latest Patents

Shira Yair holds a patent for "Humanized antibodies specific for HSP65-derived peptide-6 methods and uses thereof." This invention relates to humanized antibodies that specifically bind to a polypeptide comprising peptide-6, which is derived from HSP65. The patent outlines the use of these antibodies in treating various inflammatory disorders, including arthritis, inflammatory bowel disease (IBD), psoriasis, diabetes, and multiple sclerosis (MS). Additionally, the invention includes combined compositions and kits that incorporate these humanized antibodies along with anti-inflammatory agents, as well as their applications in diagnostic methods.

Career Highlights

Shira Yair has established herself as a key figure in her field through her innovative research and development efforts. She is currently associated with Protab Ltd., where she continues to advance her work on humanized antibodies and their therapeutic applications.

Collaborations

Shira collaborates with Yaakov Naparstek, who is also involved in the research and development of immune-related therapies. Their partnership enhances the potential for breakthroughs in the treatment of various inflammatory conditions.

Conclusion

Shira Yair's contributions to the field of biotechnology, particularly through her patent on humanized antibodies, highlight her role as an innovator in addressing immune-related disorders. Her work continues to pave the way for new therapeutic approaches that can significantly impact patient care.